Schein Settles Pair Of Investor Suits Over Price-Fixing Claims
Medical product distributor Henry Schein Inc. agreed on Thursday to pay $35 million to resolve antitrust and securities fraud claims in a proposed New York federal class action alleging it rigged...To view the full article, register now.
Already a subscriber? Click here to view full article